About NEU
Neuren Pharmaceuticals (NEU) develops therapies for serious early-childhood neurological disorders lacking approved treatments, with orphan drug designations across its US programs.
All News for NEU
No news articles found for NEU yet.
Neuren Pharmaceuticals (NEU) develops therapies for serious early-childhood neurological disorders lacking approved treatments, with orphan drug designations across its US programs.
No news articles found for NEU yet.
Get alerts when news about NEU is published